The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Cannabis and mental illness: a review
Open accessAbstract
With the increasing push to legalize cannabis in Western nations, there is a need to gage the potential impact of this policy change on vulnerable populations, such as those with mental illness, including schizophrenia, mood, and anxiety disorders. This is particularly important as there are strong motives in these individuals to seek short-term reward (e.g., “getting high”). Nonetheless, data to support the beneficial effects of cannabis use in psychiatric populations are limited, and potential harms in patients with psychotic and mood disorders have been increasingly documented. This article reviews the effects of cannabis in people with mental illness. Then, we provide a reconciliation of the addiction vulnerability and allostatic hypotheses to explain co-morbidity addiction in mentally ill cannabis users, as well as to further aid in developing a rational framework for the assessment and treatment of problematic cannabis use in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698 · cited 2×
“These neurobiological and psychological changes mark the initial process in drug use and addiction, with mesocorticolimbic dopamine transmission playing a key role alongside the other neurotransmitter activations in regions including the ventral tegmental area, nucleus accumbens, and frontal cortex [86].”
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242 · cited 3×
“The self-medication hypothesis is based on the notion that individuals use substances due to dysfunctional self-regulatory abilities and affect states [82, 83].”
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523 · cited 1×
“This includes impaired short-term memory, motor coordination and control, executive functioning, as well as altered judgement [12, 28, 101, 134].”
Groce, E. (2018) · Journal of Medical Regulation · doi:10.30770/2572-1852-104.4.32 · Cited by 1,330
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059 · cited 1×
“1 3 that were significantly associated with clinical improvements [91].”
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.004 · Cited by 995
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment
Solowij, N. (2002) · JAMA · doi:10.1001/jama.287.9.1123 · Cited by 798
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771 · cited 1×
“on the medical use of cannabinoids describes only one clinical trial conducted by Bergamaschi and colleagues in which a single 600 mg dose of CBD in individuals with SAD was associated with improved scores on a visual analog scale after a simulated public speaking test in comparison to placebo; however, the authors no…”
Crean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31820c23fa · Cited by 732 · cited 1×
“This includes impaired short-term memory, motor coordination and control, executive functioning, as well as altered judgement [12, 28, 101, 134].”
Lopez-Quintero, C., Cobos, J. P. D. L., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.004 · Cited by 704
The comorbidity of depression and substance use disorders
Swendsen, J. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00026-4 · Cited by 632
Drug addiction: the neurobiology of behaviour gone awry
Volkow, N. D., & Li, T.-K. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1539 · Cited by 625
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617
McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030325 · Cited by 617
Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., Sampson, N., & Kessler, R. C. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02902.x · Cited by 597
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588 · cited 1×
“Not only are there shared vulnerabilities, but the presence of a mental illness itself is a vulnerability factor for addiction, despite the heterogeneity across comorbidities [24, 80, 129, 136].”
Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O'Connor, J., Russo, M., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00117-5 · Cited by 588
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070907 · Cited by 579
The effects of adolescent cannabis use on educational attainment: a review
Lynskey, M., & Hall, W. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.951116213.x · Cited by 571
High-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567
Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis
Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.5 · Cited by 563
The Development and Maintenance of Drug Addiction
Wise, R. A., & Koob, G. F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.261 · Cited by 559
A neurobiological basis for substance abuse comorbidity in schizophrenia
Chambers, R. A., Krystal, J. H., & Self, D. W. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01134-9 · Cited by 548
Review of the Validity and Significance of Cannabis Withdrawal Syndrome
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1967 · Cited by 522
Hill, K. P. (2015) · JAMA · doi:10.1001/jama.2015.6199 · Cited by 508
Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence
Buckner, J. D., Schmidt, N. B., Lang, A. R., Small, J. W., Schlauch, R. C., & Lewinsohn, P. M. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.01.002 · Cited by 506 · cited 1×
“, cannabis use disorder (CUD)] is much higher in individuals with mental illness, including schizophrenia, mood and anxiety disorders, personality disorders, and post-traumatic stress disorder, compared to the general population [14, 17, 22, 67, 90].”
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006) · Addiction · doi:10.1111/j.1360-0443.2005.01322.x · Cited by 484
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt181 · Cited by 470
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
Comorbidity between substance use disorders and psychiatric conditions
Schuckit, M. A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01592.x · Cited by 422
Being stoned: a review of self‐reported cannabis effects
GREEN, B., KAVANAGH, D., & YOUNG, R. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Nabilone for the treatment of pain in fibromyalgia.
Skrabek, R. Q., Galimova, L., Ethans, K., & Perry, D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.002 · Cited by 384 · cited 1×
“Any other study assessing the benefits of cannabis on anxiety are, however, only secondary analyses within pain populations [55, 106, 133, 150].”
Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30208-5 · Cited by 377
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Vandrey, R., Raber, J. C., Raber, M. E., Douglass, B., Miller, C., & Bonn-Miller, M. O. (2015) · JAMA · doi:10.1001/jama.2015.6613 · Cited by 367
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
Walsh, Z., Callaway, R., Belle-Isle, L., Capler, R., Kay, R., Lucas, P., & Holtzman, S. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.08.010 · Cited by 347
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Sexton, M., Cuttler, C., Finnell, J. S., & Mischley, L. K. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0007 · Cited by 336
Co-Occurring Severe Mental Illness and Substance Use Disorders: A Review of Recent Research
RachBeisel, J., Scott, J., & Dixon, L. (1999) · Psychiatric Services · doi:10.1176/ps.50.11.1427 · Cited by 331
Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00363-6 · Cited by 322 · cited 1×
“In one study, continued cannabis use following psychosis onset, when compared to discontinued use, was associated with higher rates of relapse, longer hospital admissions, enhanced positive and negative symptoms, as well as a variety of negative impacts on daily functioning [126].”
Jetly, R., Heber, A., Fraser, G., & Boisvert, D. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.002 · Cited by 321
Mood Disorders and Substance Use Disorder: A Complex Comorbidity
Quello, S., Brady, K., & Sonne, S. (2005) · Science & Practice Perspectives · doi:10.1151/spp053113 · Cited by 320
Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp031 · Cited by 320
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · cited 14×
“antipsychotic, anxiolytic, anti-craving pro-cognitive, and neuroprotective effects), as it appears to have differential, and somewhat opposing, pharmacological effects compared to THC [29].”
MethodInfluentialMorrison, P. D., Zois, V., McKeown, D. A., Lee, T. D., Holt, D. W., Powell, J. F., Kapur, S., & Murray, R. M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005522 · Cited by 298
Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.587700 · Cited by 290
Fraser, G. A. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00071.x · Cited by 283 · cited 1×
“with symptoms, primarily involving insomnia in contrast to anxiety-related symptoms [10, 56].”
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
Bonn-Miller, M. O., Boden, M. T., Bucossi, M. M., & Babson, K. A. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.821477 · Cited by 281 · cited 4×
“In fact, roughly half of individuals who initially use cannabis for anxiety, depression, and insomnia do not report these same reasons for continued use cannabis [11].”
InfluentialSchuermeyer, J., Salomonsen-Sautel, S., Price, R. K., Balan, S., Thurstone, C., Min, S.-J., & Sakai, J. T. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.04.016 · Cited by 280
Cannabis and Anxiety and Depression in Young Adults
HAYATBAKHSH, M. R., NAJMAN, J. M., JAMROZIK, K., MAMUN, A. A., ALATI, R., & BOR, W. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31802dc54d · Cited by 267
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy
Narang, S., Gibson, D., Wasan, A. D., Ross, E. L., Michna, E., Nedeljkovic, S. S., & Jamison, R. N. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.10.018 · Cited by 257 · cited 1×
“Any other study assessing the benefits of cannabis on anxiety are, however, only secondary analyses within pain populations [55, 106, 133, 150].”
Boggs, D. L., Surti, T., Gupta, A., Gupta, S., Niciu, M., Pittman, B., Schnakenberg Martin, A. M., Thurnauer, H., Davies, A., D’Souza, D. C., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4885-9 · Cited by 242
Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04015.x · Cited by 237 · cited 1×
“Some studies have investigated the effects of cannabis use in the early childhood and adolescent stages, demonstrating an increased risk of developing anxiety symptoms and anxiety disorder, which was strengthened with earlier onset of cannabis use [25, 36, 68].”
Conway, K. P., Swendsen, J., Husky, M. M., He, J.-P., & Merikangas, K. R. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.01.006 · Cited by 234 · cited 1×
“Not only are there shared vulnerabilities, but the presence of a mental illness itself is a vulnerability factor for addiction, despite the heterogeneity across comorbidities [24, 80, 129, 136].”
Grotenhermen, F. (2004) · PubMed · Cited by 232
Hjorthøj, C., Østergaard, M. L. D., Benros, M. E., Toftdahl, N. G., Erlangsen, A., Andersen, J. T., & Nordentoft, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00207-2 · Cited by 230
Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?
Van Laar, M., Van Dorsselaer, S., Monshouwer, K., & De Graaf, R. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01875.x · Cited by 224
Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization
Foti, D. J., Kotov, R., Guey, L. T., & Bromet, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09020189 · Cited by 223
Frank, B., Serpell, M. G., Hughes, J., Matthews, J. N. S., & Kapur, D. (2008) · BMJ · doi:10.1136/bmj.39429.619653.80 · Cited by 207
Ersche, K. D., Williams, G. B., Robbins, T. W., & Bullmore, E. T. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.017 · Cited by 205
A new method of cannabis ingestion: The dangers of dabs?
Loflin, M., & Earleywine, M. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.05.013 · Cited by 205
Roitman, P., Mechoulam, R., Cooper-Kazaz, R., & Shalev, A. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0212-3 · Cited by 197
Tasty THC: Promises and Challenges of Cannabis Edibles
International, R., Barrus, D., Capogrossi, K., Cates, S., Gourdet, C., Peiper, N., Novak, S., Lefever, T., & Wiley, J. (2016) · doi:10.3768/rtipress.2016.op.0035.1611 · Cited by 194
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD
Bonn-Miller, M. O., Babson, K. A., & Vandrey, R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.12.008 · Cited by 192
Affect dysregulation in cannabis abusers: A study in adolescents and young adults
Dorard, G., Berthoz, S., Phan, O., Corcos, M., & Bungener, C. (2008) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-0663-7 · Cited by 184
Cannabis and depression: An integrative data analysis of four Australasian cohorts
Horwood, L. J., Fergusson, D. M., Coffey, C., Patton, G. C., Tait, R. J., Smart, D., Letcher, P., Silins, E., & Hutchinson, D. M. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.06.002 · Cited by 181
Sherva, R., Wang, Q., Kranzler, H., Zhao, H., Koesterer, R., Herman, A., Farrer, L. A., & Gelernter, J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0036 · Cited by 174
Cameron, C., Watson, D., & Robinson, J. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000180 · Cited by 171
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
Greer, G. R., Grob, C. S., & Halberstadt, A. L. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.873843 · Cited by 170
Strakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Arnold, L. M., & Amicone, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.57 · Cited by 165 · cited 1×
“One study highlights a positive association between BD and cannabis use, but with interactive effects of cannabis use and BD measures on gender and medication type [84], while the other studies describe cannabis use as predictive of longer affective episode duration, more frequent rapid cycling between mood states, as…”
The association between cannabis use and mood disorders: A longitudinal study
Feingold, D., Weiser, M., Rehm, J., & Lev-Ran, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.006 · Cited by 165
Posttraumatic stress disorder and cannabis use in a nationally representative sample.
Cougle, J. R., Bonn-Miller, M. O., Vujanovic, A. A., Zvolensky, M. J., & Hawkins, K. A. (2011) · Psychology of Addictive Behaviors · doi:10.1037/a0023076 · Cited by 161
Cannabis use and cannabis use disorders among individuals with mental illness
Lev‐Ran, S., Foll, B. L., McKenzie, K. J., George, T. P., & Rehm, J. T. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.12.021 · Cited by 160
Self-citationAssessing the public health impacts of legalizing recreational cannabis use in the USA
Hall, W., & Weier, M. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.110 · Cited by 159
Østergaard, M. L. D., Nordentoft, M., & Hjorthøj, C. (2017) · Addiction · doi:10.1111/add.13788 · Cited by 159
Brain Neuroimaging in Cannabis Use: A Review
Quickfall, J., & Crockford, D. N. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.318 · Cited by 157
Gieringer, D. H., Laurent, J. S., & Goodrich, S. (2004) · Journal of Cannabis Therapeutics · doi:10.1300/j175v04n01_02 · Cited by 146
Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09475 · Cited by 145 · cited 2×
“military veterans, who exhibit high comorbidities of cannabis use and CUD, commonly reporting the use of cannabis to cope with one’s traumatic experiences [8, 45, 62, 76, 78, 96, 102, 103, 151].”
Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170052 · Cited by 145
Changes in cannabis use among young people: impact on mental health
Copeland, J., Rooke, S. E., & Swift, W. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328361eae5 · Cited by 129
Kevorkian, S. S., Bonn‐Miller, M. O., Belendiuk, K. A., Carney, D. M., Roberson‐Nay, R., & Berenz, E. C. (2015) · Psychology of Addictive Behaviors · doi:10.1037/adb0000110 · Cited by 125
Cannabis use, depression and anxiety: A 3-year prospective population-based study
Danielsson, A., Lundin, A., Agardh, E. E., Allebeck, P., & Forsell, Y. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.045 · Cited by 124
Rasic, D. T., Weerasinghe, S. D. S., Asbridge, M., & Langille, D. B. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.09.009 · Cited by 122
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California
Nunberg, H., Kilmer, B., Pacula, R. L., & Burgdorf, J. R. (2011) · Journal of Drug Policy Analysis · doi:10.2202/1941-2851.1017 · Cited by 121
Boden, M. T., Babson, K. A., Vujanovic, A. A., Short, N. A., & Bonn‐Miller, M. O. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.12018.x · Cited by 121
Decreased respiratory symptoms in cannabis users who vaporize
Earleywine, M., & Barnwell, S. S. (2007) · Harm Reduction Journal · doi:10.1186/1477-7517-4-11 · Cited by 117
Gálvez-Buccollini, J. A., Proal, A. C., Tomaselli, V., Trachtenberg, M. A., Coconcea, C., Chun, J., Manschreck, T. C., Fleming, J., & DeLisi, L. E. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.007 · Cited by 116
Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
Carey, C. E., Agrawal, A., Bucholz, K. K., Hartz, S. M., Lynskey, M. T., Nelson, E. C., Bierut, L. J., & Bogdan, R. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00149 · Cited by 116
Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population
Tournier, M., Sorbara, F., Gindre, C., Swendsen, J. D., & Verdoux, H. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00052-0 · Cited by 115
Feingold, D., Weiser, M., Rehm, J. T., & Lev‐Ran, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.037 · Cited by 115
van der Pol, P., Liebregts, N., de Graaf, R., ten Have, M., Korf, D. J., van den Brink, W., & van Laar, M. (2013) · Addiction · doi:10.1111/add.12196 · Cited by 106
Cougle, J. R., Hakes, J. K., Macatee, R. J., Chavarria, J., & Zvolensky, M. J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.004 · Cited by 104
Metrik, J., Jackson, K. M., Bassett, S. S., Zvolensky, M. J., Seal, K. H., & Borsari, B. E. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000210 · Cited by 103
Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder
Zvolensky, M. J., Lewinsohn, P. M., Bernstein, A., Schmidt, N. B., Buckner, J. D., Seeley, J. R., & Bonn‐Miller, M. O. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.10.012 · Cited by 101
Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function
Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Oudman, E., Saliasi, E., Kahn, R. S., & Ramsey, N. F. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.008 · Cited by 101
Prognosis of schizophrenia in persons with and without a history of cannabis use
Manrique-Garcia, E., Zammit, S., Dalman, C., Hemmingsson, T., Andréasson, S., & Allebeck, P. (2014) · Psychological Medicine · doi:10.1017/s0033291714000191 · Cited by 99
Davis, G. P., Compton, M. T., Wang, S., Levin, F. R., & Blanco, C. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.018 · Cited by 95
Patterns of marijuana use among psychiatry patients with depression and its impact on recovery
Bahorik, A. L., Leibowitz, A., Sterling, S. A., Travis, A., Weisner, C., & Satre, D. D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.016 · Cited by 95
Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011
Charilaou, P., Agnihotri, K., García, P., Badheka, A., Frenia, D. S., & Yegneswaran, B. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.12.035 · Cited by 94
The association between regular marijuana use and adult mental health outcomes
Guttmannova, K., Kosterman, R., WHITE, H. R., Bailey, J. A., Lee, J. O., Epstein, M., Jones, T. M., & Hawkins, J. D. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.016 · Cited by 94
Prevalence and correlates of marijuana use in Canada, 2012.
Rotermann, M., & Langlois, K. A. (2015) · PubMed · Cited by 91
Gage, S. H., Hickman, M., Heron, J., Munafò, M. R., Lewis, G., Macleod, J., & Zammit, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122896 · Cited by 90 · cited 1×
“Again, there are also studies that describe a lack of any significant correlation after controlling for significant confounds, such as cigarette use and childhood factors [34, 57, 128, 154].”
Medicinal versus recreational cannabis use among returning veterans.
Metrik, J., Bassett, S. S., Aston, E. R., Jackson, K. M., & Borsari, B. E. (2018) · Translational Issues in Psychological Science · doi:10.1037/tps0000133 · Cited by 84
Kelley, M. E., Wan, C. R., Broussard, B., Crisafio, A., Cristofaro, S. L., Johnson, S., Reed, T., Amar, P., Kaslow, N. J., Walker, E. F., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.015 · Cited by 80
Schoeler, T., Theobald, D., Pingault, J., Farrington, D. P., Coid, J. W., & Bhattacharyya, S. (2018) · Psychological Medicine · doi:10.1017/s0033291717003658 · Cited by 79
Scholes‐Balog, K. E., Hemphill, S. A., Evans-Whipp, T. J., Toumbourou, J. W., & Patton, G. C. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.09.008 · Cited by 76
Giordano, G. N., Ohlsson, H., Sundquist, K., Sundquist, J., & Kendler, K. S. (2015) · Psychological Medicine · doi:10.1017/s0033291714001524 · Cited by 74 · cited 1×
“Cannabis use has been described as one of many environmental influences associated with an individual’s increased vulnerability towards the development of psychotic illness [13, 35, 38, 61], with approximately one in every four individuals in this population presenting with a concurrent CUD diagnosis [87].”
Reflections on treating addictive disorders: a psychodynamic perspective
Khantzian, E. J. (2012) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00234.x · Cited by 73 · cited 5×
“The belief that cannabis can be used to medicate the symptoms of mental illness combined with acute withdrawal relief, including the relief of symptoms not limited to anhedonia-like reports, anxiety and headaches, together primes reinforcement for further drug use [1, 82, 85].”
InfluentialThe association between adolescent cannabis use and anxiety: A parallel process analysis
Duperrouzel, J. C., Hawes, S. W., Lopez‐Quintero, C., Pacheco‐Colón, I., Comer, J. S., & González, R. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.11.005 · Cited by 72
Agrawal, A., Pergadia, M. L., & Lynskey, M. T. (2008) · American Journal on Addictions · doi:10.1080/10550490802019519 · Cited by 67
Piontek, D., Kraus, L., Bjarnason, Þ., Demetrovics, Z., & Ramstedt, M. (2012) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.07.010 · Cited by 67
Sami, M. B., Rabiner, E. A., & Bhattacharyya, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.011 · Cited by 66
Flórez‐Salamanca, L., Secades‐Villa, R., Budney, A. J., García–Rodríguez, O., Wang, S., & Blanco, C. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.01.013 · Cited by 65
Helle, S., Ringen, P. A., Melle, I. S., Larsen, T. K., Gjestad, R., Johnsen, E., Lagerberg, T. V., Andreassen, O. A., Kroken, R. A., Joa, I., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.027 · Cited by 60
Marijuana, Expectancies, and Post-Traumatic Stress Symptoms: A Preliminary Investigation
Earleywine, M., & Bolles, J. R. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.920118 · Cited by 53
Buckner, J. D., Zvolensky, M. J., Ecker, A. H., & Jeffries, E. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116629115 · Cited by 53
Effects of cannabis use status on cognitive function, in males with schizophrenia
Rabin, R. A., Zakzanis, K. K., Daskalakis, Z. J., & George, T. P. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.11.019 · Cited by 52
Self-citationZorrilla, E. P., Aguado, J., Haro, J. M., Barbeito, S., López-Zurbano, S., Ortiz, A., López, P., & González-Pinto, A. M. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12366 · Cited by 51
Mental health symptom severity in cannabis using and non-using Veterans with probable PTSD
Johnson, M. J., Pierce, J. D., Mavandadi, S., Klaus, J. R., DeFelice, D. C., Ingram, E. P., & Oslin, D. W. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.048 · Cited by 48
Ratheesh, A., Cotton, S., Betts, J. K., Chanen, A. M., Nelson, B., Davey, C. G., McGorry, P. D., Berk, M., & Bechdolf, A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.025 · Cited by 47
The genetic basis of the comorbidity between cannabis use and major depression
Hodgson, K., Almasy, L. A., Knowles, E. E. M., Kent, J. W., Curran, J. E., Dyer, T. D., Göring, H. H. H., Olvera, R. L., Woolsey, M. D., Duggirala, R., et al. (2016) · Addiction · doi:10.1111/add.13558 · Cited by 45
REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS
Moitra, E., Anderson, B. J., & Stein, M. D. (2015) · Depression and Anxiety · doi:10.1002/da.22460 · Cited by 44
Tull, M. T., McDermott, M. J., & Gratz, K. L. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.014 · Cited by 43
Rabin, R. A., Barr, M. S., Goodman, M. S., Herman, Y., Zakzanis, K. K., Kish, S. J., Kiang, M., Remington, G. J., & George, T. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.85 · Cited by 41
Self-citationDaily-level associations between PTSD and cannabis use among young sexual minority women
Dworkin, E. R., Kaysen, D. L., Bedard‐Gilligan, M. A., Rhew, I. C., & Lee, C. M. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.06.007 · Cited by 40
Villagonzalo, K.-A., Dodd, S., Ng, F., Mihaly, S., Langbein, A., & Berk, M. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.10.001 · Cited by 38
Sagar, K. A., Dahlgren, M. K., Racine, M. T., Dreman, M. W., Olson, D. P., & Gruber, S. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157060 · Cited by 37
Patel, R., Wilson, R. P., Jackson, R., Ball, M., Shetty, H., Broadbent, M. T. M., Stewart, R. J., McGuire, P. K., & Bhattacharyya, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60394-4 · Cited by 33
Cannabis use disorder treatment barriers and facilitators among veterans with PTSD.
Bujarski, S. J., Galang, J. N., Short, N. A., Trafton, J. A., Gifford, E. V., Kimerling, R. E., Vujanovic, A. A., McKee, L. G., & Bonn‐Miller, M. O. (2015) · Psychology of Addictive Behaviors · doi:10.1037/adb0000131 · Cited by 32
Baggio, S., N'Goran, A. A., Deline, S., Studer, J., Dupuis, M., Henchoz, Y., Mohler-Kuo, M., Daeppen, J.-B., & Gmel, G. (2014) · Addiction · doi:10.1111/add.12490 · Cited by 31
Manhapra, A., Stefanovics, E. A., & Rosenheck, R. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.036 · Cited by 29
Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder
Kim, S., Dodd, S., Berk, L., Kulkarni, J., de Castella, A. R., Fitzgerald, P. B., Kim, J., Yoon, J., & Berk, M. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.3.349 · Cited by 29
Rabin, R. A., Kozak, K., Zakzanis, K. K., Remington, G. J., & George, T. P. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.010 · Cited by 29
Self-citationGrant, S., Pedersen, E. R., & Neighbors, C. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2016.77.509 · Cited by 27
Characteristics of clinically anxious versus non-anxious regular, heavy marijuana users
Van Dam, N. T., Bedi, G., & Earleywine, M. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.05.021 · Cited by 26
Lee, J. Y., Brook, J. S., Finch, S. J., & Brook, D. W. (2017) · Substance Abuse · doi:10.1080/08897077.2017.1363121 · Cited by 25
Cannabis Legalization and Psychiatric Disorders: Caveat “Hemp-tor”
George, T. P., Hill, K. P., & Vaccarino, F. J. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718762387 · Cited by 25
Self-citationA Review of the Epidemiology of Schizophrenia
Brown, A. S., & Lau, F. S. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00002-x · Cited by 24
Case studies in cannabis vaporization
Earleywine, M., & Dam, N. T. V. (2010) · Addiction Research & Theory · doi:10.3109/16066350902974753 · Cited by 19
[The dual process model of addiction. Towards an integrated model?].
Vandermeeren, R., & Hebbrecht, M. (2012) · PubMed · Cited by 11
Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior
(2016) · Handbook of behavioral neuroscience · doi:10.1016/c2013-0-19136-2 · Cited by 11
Cited by
Kaar, S. J., Natesan, S., McCutcheon, R., & Howes, O. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 383
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
Dellazizzo, L., Potvin, S., Giguère, S., & Dumais, A. (2022) · Addiction · doi:10.1111/add.15764 · Cited by 120
Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening
Marcus, D. J., Bedse, G., Gaulden, A. D., Ryan, J. D., Kondev, V., Winters, N. D., Rosas-Vidal, L. E., Altemus, M., Mackie, K., Lee, F. S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.024 · Cited by 104
Botsford, S. L., Yang, S., & George, T. P. (2020) · The American Journal on Addictions · doi:10.1111/ajad.12963 · Cited by 88
“It is likely that there is a complex network of overlapping and multidirectional relationships that explain the high rates of comorbidity, rather than individual theories alone like the self-medication or addiction vulnerability hypothesis (Lowe et al 2018).”
Self-citation
Metadata
- Authors
- Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P.
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2018-12-19
- Volume
- 269
- Issue
- 1
- Pages
- 107-120
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2904833627
- Cited by
- 253
- References
- 151
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.